Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$52.17 - $70.2 $2.54 Million - $3.42 Million
-48,731 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$68.86 - $83.34 $3.36 Million - $4.06 Million
48,731 New
48,731 $3.36 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.58B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.